When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

North Carolina’s economy continues to outpace that of most competitors. The latest employment report from the U.S. Bureau of ...

During a live event, Hans Lee, MD, and participants shared their perspectives on current and upcoming treatment approaches in ...

Halfway through the year, these companies have pledged to hire the most workers in North Carolina. One is a record setter.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO [NCT05171647] study showing Lunsumio® (mosunetuzumab-axgb) administered subcutaneo ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III development of prasinezumab, an i ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished ...